| 000 | 01190 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512071505.0 | ||
| 264 | 0 | _c19861107 | |
| 008 | 198611s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVon Hoff, D D | |
| 245 | 0 | 0 |
_aRationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cSep 1986 |
||
| 300 |
_a72-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTumor Stem Cell Assay |
| 700 | 1 | _aSarosy, G | |
| 700 | 1 | _aBrown, T D | |
| 700 | 1 | _aKuhn, J G | |
| 700 | 1 | _aKisner, D L | |
| 773 | 0 |
_tSeminars in oncology _gvol. 13 _gno. 3 Suppl 2 _gp. 72-7 |
|
| 999 |
_c3770143 _d3770143 |
||